Lv1
80 积分 2021-11-29 加入
D21-20 SIM0712, an Oral STAT6 Degrader for the Treatment of Th2-driven Inflammatory Diseases
1个月前
已完结
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
2个月前
已完结
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
2个月前
已完结
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma
2个月前
已完结
Comprehensive analysis of phenotypes and transcriptome characteristics reveal the best atopic dermatitis mouse model induced by MC903
3个月前
已完结
Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone
4个月前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
5个月前
已完结
Comprehensive analysis of phenotypes and transcriptome characteristics reveal the best atopic dermatitis mouse model induced by MC903
6个月前
已完结
Discovery of Selective and Potent ATR Degrader for Exploration its Kinase‐Independent Functions in Acute Myeloid Leukemia Cells
8个月前
已完结
B cell-targeted therapies in systemic lupus erythematosus: Current status and perspectives
11个月前
已完结
皖公网安备34019202002308
